Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$0.4.

  • Orchestra BioMed Holdings' EPS (Basic) rose 243.9% to -$0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.82, marking a year-over-year decrease of 1304.35%. This contributed to the annual value of -$1.66 for FY2024, which is 1183.57% down from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' EPS (Basic) is -$0.4, which was up 243.9% from -$0.5 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' EPS (Basic) registered a high of -$0.35 during Q2 2023, and its lowest value of -$0.77 during Q2 2022.
  • Over the past 4 years, Orchestra BioMed Holdings' median EPS (Basic) value was -$0.44 (recorded in 2024), while the average stood at -$0.46.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 5454.55% in 2023, then tumbled by 2894.74% in 2025.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' EPS (Basic) stood at -$0.44 in 2022, then grew by 15.91% to -$0.37 in 2023, then dropped by 18.58% to -$0.44 in 2024, then increased by 8.83% to -$0.4 in 2025.
  • Its EPS (Basic) was -$0.4 in Q3 2025, compared to -$0.5 in Q2 2025 and -$0.49 in Q1 2025.